TNN

Present Fundamentals: Mallinckrodt (NYSE: MNK)
TNN
It reached an intraday high of 26.78 and a low of 25.05. PR Newswire: First Patient Screened in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or

and more »

X